clinical trial · NCT07361289
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
Bristol-Myers Squibb·—·recruiting·n = 500
Hypertrophic CardiomyopathyMavacamten
brief summary
The purpose of this study is to assess the effectiveness of mavacamten treatment in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM) in real-world clinical practice
started
Jan 15, 2026
primary completion
Aug 22, 2028
completion
Aug 28, 2028
last updated
Jun 18, 2026
official title
A Single-Arm Observational Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol